Medite Cancer Diagnostics, Inc.
Medite Cancer Diagnostics, Inc. (MDIT) Market Cap & Net Worth
Live market cap, enterprise value, and global rank — multi-year chart and annual table below.
mdit · market cap & enterprise value · FMP · as of Jun 5, 2026
Core market cap & key metrics
As of Jun 5, 2026, Medite Cancer Diagnostics, Inc. (MDIT) has a market cap — also referred to as its net worth or valuation — of $8,672, making it one of the top most valuable companies globally. Market Cap = $0.00 × shares outstanding.
Market cap history — by year
* 2026 = year-to-date · Year-end market cap · Source: FMP
Market cap by year
Compared to Peers
View Healthcare sectorAbout Market Cap, Net Worth & Valuation
Medite Cancer Diagnostics, Inc. (MDIT) has a market cap — also referred to as its net worth or valuation — of $8,672 as of Jun 5, 2026, making it the #0 most valuable company globally. Market Cap = Stock Price × Shares Outstanding.
Medite Cancer Diagnostics, Inc. reached its all-time high market cap of $3.2B on Jul 15, 2021. Comparing the Medite Cancer Diagnostics, Inc. market cap history illustrates one of the most extraordinary corporate growth stories.
Investors frequently compare Medite Cancer Diagnostics, Inc. net worth vs peers and ask how Medite Cancer Diagnostics, Inc. valuation compares to other countries. Its market cap reflects continued investor confidence.
Frequently Asked Questions
MDIT market cap · 6 questionsMedite Cancer Diagnostics, Inc.'s net worth — measured as market capitalization — is $8,672 as of Jun 5, 2026. It ranks #0 globally. Market Cap = $$0.00 (price) × shares outstanding.